Agilent Technologies (NYSE:A) Releases Q2 2025 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.250-1.280 for the period, compared to the consensus EPS estimate of 1.310. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock traded down $0.39 during trading on Friday, hitting $126.70. 612,594 shares of the company’s stock traded hands, compared to its average volume of 1,693,555. Agilent Technologies has a 1 year low of $124.16 and a 1 year high of $155.35. The business has a 50-day simple moving average of $140.78 and a 200-day simple moving average of $139.20. The stock has a market capitalization of $36.14 billion, a P/E ratio of 29.12, a PEG ratio of 3.64 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.58%. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. As a group, analysts forecast that Agilent Technologies will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.78%. Agilent Technologies’s dividend payout ratio (DPR) is 22.76%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Wells Fargo & Company reduced their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Robert W. Baird reduced their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday. Bank of America decreased their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Finally, Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $135.00 to $145.00 in a report on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $146.15.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.